| A novel microRNA-132-surtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis Y Miyazaki, R Li, A Rezk, H Misirliyan, C Moore, N Farooqi, M Solis, ... Plos one 9 (8), e105421, 2014 | 96 | 2014 |
| Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study R Li, TF Tropea, LR Baratta, L Zuroff, ME Diaz-Ortiz, B Zhang, K Shinoda, ... Neurology-Neuroimmunology Neuroinflammation 9 (2), 2022 | 35 | 2022 |
| Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis I Mexhitaj, MH Nyirenda, R Li, J O’Mahony, A Rezk, A Rozenberg, ... Brain 142 (3), 617-632, 2019 | 80 | 2019 |
| Abnormal Frequency and Function of MR1-defined MAIT cells in Pediatric Multiple Sclerosis (S55. 007) I Mexhitaj, M Nyirenda, R Li, J O’Mahony, A Rezk, A Rosenberg, C Moore, ... Neurology 92 (15 Supplement), 2019 | 1 | 2019 |
| Abnormal functional phenotypes of effector and regulatory T-cell subsets in pediatric-onset MS M Nyirenda, R Li, CS Moore, A Rozenberg, A Rezk, T Johnson, ... MULTIPLE SCLEROSIS JOURNAL 20, 314-315, 2014 | | 2014 |
| Abnormal responses of CD8+ CD161high mucosal associated invariant T (MAIT) cells and CCR2+ CCR5+ CD4 T cells contribute to disrupted balance of effector and regulatory T cells … M Nyirenda, R Li, C Moore, A Rozenberg, A Rezk, T Johnson, ... Journal of Neuroimmunology 275 (1), 203-204, 2014 | | 2014 |
| Antibody-independent function of human B cells contributes to antifungal T cell responses R Li, A Rezk, H Li, JL Gommerman, A Prat, A Bar-Or The Journal of Immunology 198 (8), 3245-3254, 2017 | 49 | 2017 |
| Assessing the Balance Between Effector and Regulatory T cell Subsets in Pediatric Multiple Sclerosis (S55. 006) I Mexhitaj, M Nyirenda, R Li, J O’Mahony, A Rezk, A Rosenberg, C Moore, ... Neurology 92 (15 Supplement), 2019 | | 2019 |
| B Cells Selectively Induce CD8+ MAIT Cell Effector Functions: Implications for Multiple Sclerosis (5355) A Rezk, K Shinoda, R Li, A Bar-Or Neurology 94 (15 Supplement), 2020 | | 2020 |
| Canadian B cells in MS Team. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy R Li, A Rezk, Y Miyazaki, E Hilgenberg, H Touil, P Shen, CS Moore, ... Sci. Transl. Med 7 (310), 310ra166, 2015 | 49 | 2015 |
| Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy SA Apostolidis, M Kakara, MM Painter, RR Goel, D Mathew, K Lenzi, ... Nature medicine 27 (11), 1990-2001, 2021 | 444 | 2021 |
| Cellular immune profiling pre-and post-aCD20 therapy points to differential effects on CD4 (+) and CD8 (+) T cells and implicates CD20-expressing CD8 (+) T cells in MS disease … K Shinoda, R Li, A Rezk, I Mexhitaj, KR Patterson, M Kakara, L Zuroff, ... | | 2021 |
| Characterization of age-related changes in circulating t cells in multiple sclerosis and normal controls: a pilot study L Zuroff, R Li, K Shinoda, A Rezk, A Bar-Or MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 570-570, 2020 | | 2020 |
| Correction: Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis R Li, A Rezk, M Ghadiri, F Luessi, F Zipp, H Li, PS Giacomini, J Antel, ... The Journal of Immunology 202 (7), 2172-2172, 2019 | | 2019 |
| Cytokine-defined B cell responses as therapeutic targets in multiple sclerosis R Li, A Rezk, LM Healy, G Muirhead, A Prat, JL Gommerman, A Bar-Or, ... Frontiers in Immunology 6, 626, 2016 | 112 | 2016 |
| Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity K Shinoda, R Li, A Rezk, I Mexhitaj, KR Patterson, M Kakara, L Zuroff, ... Proceedings of the National Academy of Sciences 120 (3), e2207291120, 2023 | 23 | 2023 |
| Dimethyl fumarate treatment mediates an anti-inflammatory shift in B cell subsets of patients with multiple sclerosis R Li, A Rezk, M Ghadiri, F Luessi, F Zipp, H Li, PS Giacomini, J Antel, ... The Journal of Immunology 198 (2), 691-698, 2017 | 129 | 2017 |
| Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosis M Ghadiri, A Rezk, R Li, A Evans, F Luessi, F Zipp, PS Giacomini, J Antel, ... Neurology-Neuroimmunology Neuroinflammation 4 (3), 2017 | 84 | 2017 |
| DMF induces differential apoptosis of T cell subsets and leads to a shift in the regulatory to effector T cell balance in MS patients M Ghadiri, A Rezk, R Li, F Luessi, F Zipp, J Antel, PS Giacomini, A Bar-Or MULTIPLE SCLEROSIS JOURNAL 22, 310-311, 2016 | | 2016 |
| Early Preferential Repletion Of Anti-inflammatory B Cells Following An Initial Cycle Of Ocrelizumab In Patients With Multiple Sclerosis K Shinoda, A Rezk, R Li, A Bar-Or MULTIPLE SCLEROSIS JOURNAL 26 (1_ SUPPL), 59-59, 2020 | | 2020 |
